Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase …

Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase …
Lilly currently has eight potential new medicines in its clinical development pipeline being evaluated to treat neuroscience-related diseases and disorders, including: schizophrenia, Alzheimer's disease, depression, bipolar disorder, migraine … Read more on PR Newswire (press release)

Antidepressants: Ineffective, but Harmful?
Barbie and The Aspirin If you've been staying up on medication news, you are probably aware that a lot of the recent literature has pointed to the inefficacy of antidepressants for patients with bipolar disorder. Now, a study from Brown University in … Read more on PsychCentral.com (blog)